Half of pancreatic cancer patients not prescribed tablets they need to stop them starving, new research shows
We launch our new ‘Transform Lives: Prescribe’ campaign, urging the NHS to ensure everyone who could benefit from pancreatic enzyme replacement therapy is prescribed them at the point of diagnosis.
Scotmid Co-operative partner with Pancreatic Cancer UK
Scotmid Co-operative partner with Pancreatic Cancer UK to invest in pancreatic cancer research in Scotland
A statement from our Chair of Trustees, Lynne
We’ll get through this, together.
Coronavirus (COVID-19) statement for supporters of Pancreatic Cancer UK
We are adapting to unprecedented circumstances but we won’t be deterred from our mission. We won’t stop until we have transformed the future for everyone affected by pancreatic cancer.
Deadliest cancers have received just 7% of research funding over 10 years
The Less Survivable Cancers Taskforce is calling on the government to end the vicious cycle of research neglect.
Pancreatic Cancer UK funds study to search for pancreatic cancer ‘DNA fingerprint’
Oxford University researchers are testing a new technique to identify the ‘DNA fingerprint’ of pancreatic cancer in the blood of patients